Seshadri C Mudumbai
Biographic Data
| ID | 7873723 |
|---|---|
| NAME | Seshadri C Mudumbai |
| GIVEN NAMES | Seshadri C |
| FAMILY NAME | Mudumbai |
| SIGNATURE | MUDUMBAI S C |
| AFFILIATIONS | VA Palo Alto Health Care System |
| ORCID | 0000-0001-8486-9966 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials
The impact of agonist dose and of physician, staff and patient engagement on treatment have not been evaluated together in an analysis of treatment for opioid use disorder. Our hypotheses were that greater agonist dose and therapeutic engagement would be associated with reduced illicit opiate use in a time-dependent manner. Publicly-available treatment data from six buprenorphine efficacy and safety trials from the Federally-supported Clinical Tr…
No prominent works on this page.
Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials
The impact of agonist dose and of physician, staff and patient engagement on treatment have not been evaluated together in an analysis of treatment for opioid use disorder. Our hypotheses were that greater agonist dose and therapeutic engagement would be associated with reduced illicit opiate use in a time-dependent manner. Publicly-available treatment data from six buprenorphine efficacy and safety trials from the Federally-supported Clinical Tr…
Buprenorphine (1 work) · Drug (1 work) · Illicit drug (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Naltrexone (1 work) · Opiate (1 work) · Opiate Substitution Treatment (1 work) · Opioid (1 work) · Opioid epidemic (1 work)